Atlantic Union Bankshares Corp Sarepta Therapeutics, Inc. Transaction History

Atlantic Union Bankshares Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 01, 2021	SELL	$125.56 - $178.74 $188,340 - $268,110	-1,500 Closed	0 $0
Q2 2020 Jul 15, 2020	BUY	$93.0 - $171.7 $139,500 - $257,549	1,500 New	1,500 $241,000
Q1 2020 Apr 10, 2020	SELL	$82.38 - $131.64 $164,760 - $263,280	-2,000 Closed	0 $0
Q4 2019 Jan 14, 2020	BUY	$76.53 - $135.58 $153,060 - $271,160	2,000 New	2,000 $258,000
Q3 2019 Oct 17, 2019	SELL	$72.81 - $156.91 $182,025 - $392,275	-2,500 Closed	0 $0
Q2 2019 Jul 23, 2019	BUY	$112.21 - $151.95 $280,525 - $379,875	2,500 New	2,500 $380,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Atlantic Union Bankshares Corp, based on Form 13F filings with the SEC.

Stay updated on Atlantic Union Bankshares Corp with notifications on news.